Mycophenolate Mofetil

규격

128794-94-5CAS 번호

627-027-6EC 번호

2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoateIUPAC 명칭

C23H31NO7화학식

433.5 g/mol분자량

mycophenolate mofetil; 128794-94-5; 115007-34-6; Myfenax; RS 61443; RS-61443; myclausen; Mycophenylate mofetil; Mycophenolic acid morpholinoethyl ester; Mycophenolate mofetil Teva; MYHIBBIN; Arzip; DTXSID3023340; 2-(morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate; NSC-724229; NSC-758905; CHEBI:8764; 9242ECW6R0; 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; DTXCID103340; 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (E)-; NSC724229; MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER; Mofetil, Mycophenolate; RefChem:55675; 627-027-6; CellCept; TM-MMF; 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate; MFCD00867568; 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)-; Cellcept (TN); 2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate; C23H31NO7; (E)-2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate; Mycophenolate mofetil (CellCept); Munoloc; 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate; 2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate; Mycophenolate Mofetil (E/Z mixture); 1076198-64-5; 2-Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate; 6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester; SMR002544686; MMF CellCept(TM); CAS-128794-94-5; HSDB 7436; ME-MPA; SR-05000001485; Mycophenolate mofetil [USAN]; UNII-9242ECW6R0; Mycophenolate Mofetil (Rs-61443); Mycophenolatmofetil; Mycophenolate mofetil [USAN:USP]; NCGC00159459-02; mycophenolate-mofetil; R-99; Mycophenolate mofetil CRS; SCHEMBL4195; CHEMBL1456; 140401-05-4; MLS003915627; MLS004774133; MLS006011929; 2-(4-morpholinyl)ethyl ester; GTPL6831; orb1225543; orb1226608; orb1226907; orb1300896; orb1310798; orb3141247; SCHEMBL29378681; CHEBI:93612; HY-B0199R; Mycophenolate Mofetil (Standard); Mycophenolate mofetil (JAN/USP); GLXC-06676; HMS2090A03; HMS5079C12; Pharmakon1600-01504567; MYCOPHENOLATE MOFETIL [JAN]; ALBB-027273; HY-B0199; MYCOPHENOLATE MOFETIL [HSDB]; Tox21_111686; BDBM50248299; EBC-11251; MSK001604; MYCOPHENOLATE MOFETIL [VANDF]; NSC758905; s1501; STL146382; MYCOPHENOLATE MOFETIL [MART.]; AKOS005720900; MYCOPHENOLATE MOFETIL [USP-RS]; MYCOPHENOLATE MOFETIL [WHO-DD]; Tox21_111686_1; AC-1562; CCG-213315; DB00688; FM26106; KS-1209; NSC 724229; NSC 758905; MYCOPHENOLATE MOFETIL [EMA EPAR]; Mycophenolate mofetil, >=98% (HPLC); NCGC00159459-03; NCGC00159459-04; NCGC00159459-15; 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate; BM164622; LS-15013; Mycophenolate mofetil - Bio-X trade mark; SMR004703518; SY057966; MYCOPHENOLATE MOFETIL [ORANGE BOOK]; MYCOPHENOLATE MOFETIL [EP MONOGRAPH]; M2387; MYCOPHENOLATE MOFETIL [USP MONOGRAPH]; NS00006994; SW219893-1; T6293; C07908; D00752; SBI-0653417.0001; W18801; AB01274794-01; AB01274794-02; AB01274794_03; AB01274794_04; EN300-1705962; Mycop henolic acid 2-(4-morpholinyl)ethyl ester; Mycophenolate mofetil for peak identification CRS; F802474; M964098; Mycophenolate mofetil 100 |Ig/mL in Acetonitrile; Mycophenolate mofetil 100 microg/mL in Acetonitrile; Q4567614; SR-05000001485-1; SR-05000001485-2; BRD-K92428153-001-01-0; BRD-K92428153-001-04-4; BRD-K92428153-001-05-1; Z2568665233; MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER [MI]; Mycophenolate mofetil, European Pharmacopoeia (EP) Reference Standard; Mycophenolate mofetil, United States Pharmacopeia (USP) Reference Standard; Mycophenolate mofetil for peak identification, European Pharmacopoeia (EP) Reference Standard; Mycophenolate Mofetil, Pharmaceutical Secondary Standard; Certified Reference Material; (4E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)4-HEXENOIC ACID 4-METHYL-2-(4-MORPHOLINYL)ETHYL ESTER; (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid 2-(4-Morpholinyl)ethyl Ester; 2-(4-MORPHOLINO)ETHYL (E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL)-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOATE; 2-(4-Morpholinyl)ethyl (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate; 2-(Morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex4-enoate; 4-Hexenoic acid,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E); 4-HEXENOIC ACID,6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-,2-(4-MORPHOLINYL)ETHYL ESTER; morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate; Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)- 4-methylhex-4-enoate; Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate; Morpholinoethyl E-6-(1,3-dihydro-4-hydroxy-6-methoxy-7methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate동의어